https://www.aigom.it/wp-content/uploads/2024/09/loc-savethedateaigom.png981690Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2024-09-16 08:13:522024-09-16 08:13:52ROPI-SAVE THE DATE: VERONA 29 MARZO 2025-PROGETTO CANOA CARCINOMA MAMMARIO: QUALI NOVITA’ PER IL 2025? 15 ° EDIZIONE
https://www.aigom.it/wp-content/uploads/2024/09/art.10.09.png1179960Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2024-09-09 07:33:322024-09-09 07:33:32DURABILITY OF RESPONSE WITH SELPERCATINIB IN PATIENTS WITH RET-ACTIVATED THYROID CANCER: LONG-TERM SAFETY AND EFFICACY FROM LIBRETTO-001.
https://www.aigom.it/wp-content/uploads/2024/08/ART.02.09.png1098960Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2024-09-02 07:29:032024-08-30 07:57:18OXALIPLATIN-BASED ADJUVANT CHEMOTHERAPY IN OLDER PATIENTS WITH STAGE III COLON CANCER: AN ACCENT/IDEA POOLED ANALYSIS OF 12 TRIALS.
